Open access · OA
via OpenAlex
Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy
Laura de Girolamo, Enrico Lucarelli, Giulio Alessandri, Maria Antonietta Avanzini, Maria Ester Bernardo, Ettore Biagi, Anna Teresa Brini, Giovanna D’Amico, Franca Fagioli, Ivana Ferrero, Franco Locatelli, Rita Maccario, Mario Marazzi, Ornella Parolini, Augusto Pessina
Current Pharmaceutical Design · 2013 · ▲ 163 citations
Abstract
Mesenchymal stem cells (MSCs) were first isolated more than 50 years ago from the bone marrow. Currently MSCs may also be isolated from several alternative sources and they have been used in more than a hundred clinical trials worldwide to treat a wide variety of diseases. The MSCs mechanism of action is undefined and currently under investigation. For in vivo purposes MSCs must be produced in compliance with good manufacturing practices and this has stimulated research on MSCs characterization and safety. The objective of this review is to describe recent developments regarding MSCs properties, physiological effects, delivery, clinical applications and possible side effects. Keywords: Mesenchymal stem/stromal cells, cell therapy, graft versus host disease, immunomodulatory properties, regenerative medicine, advanced therapy medicinal product, transplantation, MSCs sources, clinical trials, clinical applications
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/1381612811319130015
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Girolamo, L.D., Lucarelli, E., Alessandri, G., Avanzini, M.A., Bernardo, M.E., Biagi, E., Brini, A.T., D’Amico, G., Fagioli, F., Ferrero, I., Locatelli, F., Maccario, R., Marazzi, M., Parolini, O., Pessina, A., & Group, M.I.M.S.C. (2013). Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy. <em>Current Pharmaceutical Design</em>. https://doi.org/10.2174/1381612811319130015
Vancouver
Girolamo LD, Lucarelli E, Alessandri G, Avanzini MA, Bernardo ME, Biagi E, et al. Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy. Current Pharmaceutical Design. 2013. doi:10.2174/1381612811319130015.
BibTeX
@article{laura2013Mesenc,
title = {Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy},
author = {Laura de Girolamo and Enrico Lucarelli and Giulio Alessandri and Maria Antonietta Avanzini and Maria Ester Bernardo and Ettore Biagi and Anna Teresa Brini and Giovanna D’Amico and Franca Fagioli and Ivana Ferrero and Franco Locatelli and Rita Maccario and Mario Marazzi and Ornella Parolini and Augusto Pessina and Maria Italian Mesenchymal Stem Cell Group},
journal = {Current Pharmaceutical Design},
year = {2013},
doi = {10.2174/1381612811319130015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
Journal of Biomedical Science 2021
Open access · CC-BY
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
Journal of Internal Medicine 2007
Open access · OA
Immunomodulation by mesenchymal stem cells and clinical experience
Bio-Medical Materials and Engineering 2017
Citation only
Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine
Cell Transplantation 2016
Open access · OA
Clinical Trials with Mesenchymal Stem Cells: An Update
Stem Cells International 2018
Open access · CC-BY